Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children
Michela Sali(Università Cattolica del Sacro Cuore), Giovanni Delogu(Università Cattolica del Sacro Cuore), Basem Battah(Agostino Gemelli University Polyclinic), Teresa Chiacchio(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Danilo Buonsenso(Università Cattolica del Sacro Cuore), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Piero Valentini(Agostino Gemelli University Polyclinic), Pamela D’Alfonso(Università Cattolica del Sacro Cuore), Ivana Palucci(Institute of Microbiology), Manuela Ceccarelli(Università degli Studi di Enna Kore), Maurizio Sanguinetti(Università Cattolica del Sacro Cuore), Flavio De Maio(Università Cattolica del Sacro Cuore)
Cited by 43
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445
Grain yield, nitrogen-use efficiency and baking quality of old and modern Italian bread-wheat cultivars grown at different nitrogen levels
|European Journal of Agronomy|2003|360